Matches in Nanopublications for { ?s ?p "[RI-HER2 was significantly more frequent in tumors with two or more recurrences (40.7% versus 15.8%, P = 0.010) and in those with carcinoma in situ (CIS) (35.4% versus 15.9%, P = 0.029).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP252058.RAUL-FYGd_siR69BPKVa6AMlovCN2Rjfz7avy_MrAC0QQ130_assertion description "[RI-HER2 was significantly more frequent in tumors with two or more recurrences (40.7% versus 15.8%, P = 0.010) and in those with carcinoma in situ (CIS) (35.4% versus 15.9%, P = 0.029).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252058.RAUL-FYGd_siR69BPKVa6AMlovCN2Rjfz7avy_MrAC0QQ130_provenance.
- NP378730.RASXfuniDhmIeY5IobnvKON53FkygNkbnRYilNGZbRG3Q130_assertion description "[RI-HER2 was significantly more frequent in tumors with two or more recurrences (40.7% versus 15.8%, P = 0.010) and in those with carcinoma in situ (CIS) (35.4% versus 15.9%, P = 0.029).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378730.RASXfuniDhmIeY5IobnvKON53FkygNkbnRYilNGZbRG3Q130_provenance.